U.S. Federal regulators have approved a medication to boost low sex drive for women. It comes in the form of a shot to the thigh or abdomen. The developer for the women’s drug, Amag Pharmaceuticals, declined to release pricing information. The drug, bremelanotide, will be marketed under the name Vyleesi, the FDA said in a statement. It will be used to treat premenopausal women with a hypoactive sexual desire disorder, which is defined by a persistent lack of interest in sex, causing stress. Side effects include nausea, vomiting, injection site reaction and headaches.
This approval, from the Food and Drug Administration, adds a second drug to the market aimed at raising women’s sexual desires. The other is a daily pill that received FDA clearance in 2015. Viagra for men has been around since the 1990s.
To read the F.D.A. approval: CLICK HERE (You will be redirected)
Photo Credit: Amag Pharmaceuticals via CNN